Physician profile

Patton P Morrison-Barton

Obstetrics & Gynecology · Mobile, AL

NPI 1275560211

$4,976.76

in general payments reported to CMS, 2019-2025

41 companies · $998 in 2025

The $998 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,487.17
Education$94.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $644.48 2019-2025 Veozah, Myrbetriq
Mayne Pharma Commercial LLC $570.16 2022-2025
Abbvie INC. $500.16 2019-2023
Pfizer INC. $416.16 2019-2024
Sumitomo Pharma America, INC. $390.13 2023-2025 Myfembree, Gemtesa
Bayer Healthcare Pharmaceuticals INC. $353.80 2019-2025
Shield Therapeutics INC $259.10 2023-2025 Accrufer
Exeltis, USA INC. $190.13 2019-2025 Slynd
Mylan Pharmaceuticals INC. $163.32 2020-2022
Sage Therapeutics, LLC $150.11 2024-2025 Zurzuvae
Hologic Sales and Service, LLC $143.44 2019-2025 Aptima, Acessa Provu System
Therapeuticsmd, INC. $129.28 2019-2022
Coopersurgical, INC. $100.32 2020-2023 Paragard T 380a
Organon LLC $87.68 2022-2025 Nexplanon, Jada System
Meditrina $77.95 2022-2023
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Myovant Sciences INC. $77.07 2021-2022
Ethicon US, LLC $71.23 2019-2021
Lsi Solutions INC $47.10 2021-2023 Fornisee
Avion Pharmaceuticals $39.83 2019-2021
Supernus Pharmaceuticals, INC. $38.77 2025 Qelbree
Agile Therapeutics, INC. $37.28 2021-2022
Scynexis, INC. $36.99 2022
Duchesnay USA Incorporated $36.74 2019
Millicent US INC $36.61 2024-2025 Intrarosa, Femring
Evofem Biosciences, INC. $36.14 2021-2025 Phexxi, Solosec, Phexx
Amag Pharmaceuticals, INC. $34.24 2019
Monaghan Medical Corporation $33.19 2024 Aerochamber
Takeda Pharmaceuticals U.S.A., INC. $31.93 2019-2020
Idorsia Pharmaceuticals US INC $30.00 2023 Quviviq
Endo Pharmaceuticals INC. $28.60 2019-2021
Northgate Technologies, INC. $24.12 2024 Stimsite
Urovant Sciences INC $19.45 2022
Daiichi Sankyo INC. $19.37 2021
Biom'Up France Sas $18.75 2021
Novo Nordisk INC $18.40 2024 Wegovy
Caldera Medical, INC $17.17 2023 Desara
Mission Pharmacal Company $15.48 2019
Becton, Dickinson and Company $14.72 2024 Bd Max System, Bd Max Instrument
Merck Sharp & Dohme LLC $13.11 2023 Gardasil 9
Lupin INC. $12.35 2019
Amgen INC. $11.90 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Patton P Morrison-Barton

$4,976.76

in general payments reported 2019-2025

Years
2019-2025
Top company
Astellas Pharma US INC
Context
The $998 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/239004/patton-p-morrison-barton

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.